
How Politics Muddied the Waters on a Promising COVID-19 Treatment
On the eve of the Republican National Convention, Trump pressured the FDA to allow emergency use of convalescent plasma—before the agency was ready to do so
Michael S. Kinch is associate vice chancellor, professor of biochemistry and molecular biophysics and director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis. He is the author of Between Hope and Fear: A History of Vaccines and Human Immunity (Pegasus Books, 2018) and two other books.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account